RenovoRx Financials
| RNXT Stock | USD 1.29 0.08 6.61% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.19 | 1.2477 |
|
|
The essential information of the day-to-day investment outlook for RenovoRx includes many different criteria found on its balance sheet. An individual investor should monitor RenovoRx's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in RenovoRx.
Net Income |
|
RenovoRx | Select Account or Indicator |
Understanding current and past RenovoRx Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of RenovoRx's financial statements are interrelated, with each one affecting the others. For example, an increase in RenovoRx's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in RenovoRx's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of RenovoRx. Check RenovoRx's Beneish M Score to see the likelihood of RenovoRx's management manipulating its earnings.
RenovoRx Stock Summary
RenovoRx competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, and Seres Therapeutics. RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California. Renovorx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US75989R1077 |
| CUSIP | 75989R107 |
| Location | California; U.S.A |
| Business Address | 4546 El Camino |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | renovorx.com |
| Phone | 650 284 4433 |
| Currency | USD - US Dollar |
RenovoRx Key Financial Ratios
| Return On Equity | -1.55 | ||||
| EBITDA | (11.39 M) | ||||
| Net Income | (10.23 M) | ||||
| Cash Per Share | 1.19 X | ||||
| Current Ratio | 10.01 X |
RenovoRx Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining RenovoRx's current stock value. Our valuation model uses many indicators to compare RenovoRx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RenovoRx competition to find correlations between indicators driving RenovoRx's intrinsic value. More Info.RenovoRx is rated third in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, RenovoRx's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value RenovoRx by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.RenovoRx Systematic Risk
RenovoRx's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. RenovoRx volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on RenovoRx correlated with the market. If Beta is less than 0 RenovoRx generally moves in the opposite direction as compared to the market. If RenovoRx Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one RenovoRx is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of RenovoRx is generally in the same direction as the market. If Beta > 1 RenovoRx moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in RenovoRx Stock are looking for potential investment opportunities by analyzing not only static indicators but also various RenovoRx's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of RenovoRx growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
RenovoRx November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of RenovoRx help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of RenovoRx. We use our internally-developed statistical techniques to arrive at the intrinsic value of RenovoRx based on widely used predictive technical indicators. In general, we focus on analyzing RenovoRx Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build RenovoRx's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.35 | |||
| Information Ratio | 0.0849 | |||
| Maximum Drawdown | 40.06 | |||
| Value At Risk | (5.17) | |||
| Potential Upside | 7.21 |
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.